Finance

Beta
Lists
NEOG:NASDAQ
Neogen Corp
$8.97
-3.55%
(-0.33) 1D
$8.97
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
$9.32
High
$9.40
Low
$8.93
Mkt. cap
1.95B
Avg. vol.
2.51M
Volume
4.43M
52-wk high
$11.42
52-wk low
$4.53
EPS
-$2.80
Beta
1.84
Shares outstanding
217.67M
No. of employees
3K
Open
$9.32
High
$9.40
Low
$8.93
Mkt. cap
1.95B
Avg. vol.
2.51M
Volume
4.43M
52-wk high
$11.42
52-wk low
$4.53
EPS
-$2.80
Beta
1.84
Shares outstanding
217.67M
No. of employees
3K
News stories
From sources across the web
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees2.97K
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Last report
Apr 9, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.09 / $0.05
+68.76%beat
Revenue / Est. (USD)
211.20M / 204.62M
+3.22%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
225.46M
209.19M
224.69M
211.20M
Cost of goods sold
137.20M
114.22M
118.01M
112.20M
Cost of revenue
137.20M
114.22M
118.01M
112.20M
Research and development expenses
6.31M
5.12M
4.56M
3.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.70M
105.94M
107.50M
98.50M
Operating expense
113.01M
111.06M
112.06M
102.30M
Total operating expenses
250.21M
225.28M
230.07M
214.50M
Operating income
-24.75M
-16.09M
-5.38M
-3.30M
Other non operating income
-3.35M
-1.10M
-477.00K
-3.10M
EBT including unusual items
-631.20M
43.81M
-20.36M
-20.30M
EBT excluding unusual items
-47.94M
-32.58M
-20.36M
-20.30M
Income tax expense
-19.01M
7.47M
-4.44M
-3.30M
Effective tax rate
3.01%
17.05%
21.80%
16.26%
Other operating expenses
-
-
-
-
Net income
-612.20M
36.34M
-15.92M
-17.00M
Net profit margin
-271.53%
17.37%
-7.09%
-8.05%
Earnings per share
0.05
0.04
0.10
0.09
Interest and investment income
644.00K
918.00K
592.00K
-
Interest expense
-17.13M
-16.44M
-14.85M
-13.90M
Net interest expenses
-16.48M
-15.52M
-14.26M
-13.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.51M
12.96M
23.55M
25.62M
Gain or loss from assets sale
-124.00K
-75.69M
267.00K
224.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more